✦ LIBER ✦

A phase I trial of andrographolide in HIV positive patients and normal volunteers

✍ Scribed by Carlo Calabrese; Sheryl H. Berman; John G. Babish; Xinfang Ma; Lynne Shinto; Melissa Dorr; Kameron Wells; Cynthia A. Wenner; Leanna J. Standish

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 78 KB
Volume: 14
Category: Article
ISSN: 0951-418X
DOI: 10.1002/1099-1573(200008)14:5<333::aid-ptr584>3.0.co;2-d

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I trial with oral oxihumate in HIV

Phase I trial with oral oxihumate in HIV-infected patients

✍ Mariëtte E. Botes; J. Dekker; C.E.J. van Rensburg 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

## Abstract Oxihumate is formed through conversion of bituminous coal by controlled wet oxidation. The objective of the study, based on in vitro studies, was to evaluate the safety and toxicity profile of oxihumate at various doses in HIV‐1‐infected individuals. Thirty‐seven antiretroviral‐naïve ad

A Phase I trial of weekly lomustine in p

A Phase I trial of weekly lomustine in patients with advanced cancer

✍ Charles A. Koller; Carolyn C. Gorski; Robert S. Benjamin; Sewa S. Legha; Nichola 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB 👁 2 views

Study of belching ability in antireflux

Study of belching ability in antireflux surgery patients and normal volunteers

✍ D. Smith; N. A. King; B. Waldron; P. T. Cullen; B. Millar; M. Fenwick; Mr F. C. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 400 KB

A phase I trial of dactinomycin intraven

A phase I trial of dactinomycin intravenous infusion in patients with advanced malignancies

✍ Martin S. Blumenreich; Thomas M. Woodcock; Stephen P. Richman; Mariesa K. Jones; 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 3 views

Eighteen patients with advanced malignancies refractory to other forms of treatment were given dactinomycin (Act D) as continuous intravenous infusions. Their median age was 51 years (range, 36-67); their median performance status was 50 (range, 40-90) on the Karnofsky scale. Act D was administered

Phase I trial of weekly docetaxel and ge

Phase I trial of weekly docetaxel and gemcitabine in patients with refractory malignancies

✍ Tarek Mekhail; Thomas E. Hutson; Paul Elson; G. Thomas Budd; Gordon Srkalovic; T 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

## Abstract ## BACKGROUND A Phase I study using weekly docetaxel and gemcitabine was conducted to investigate toxicity; to determine the maximum tolerated dose (MTD) of each agent; and, in a preliminary fashion, to determine the antitumor activity of the combination. ## METHODS Docetaxel and gem

Phase I trial of extracellular adenosine

Phase I trial of extracellular adenosine 5′-triphosphate in patients with advanced cancer

✍ Haskell, Charles M.; Wong, Maylene; Williams, Adrian; Lee, Le-Young 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 883 KB

Adenosine 5'-triphosphate (ATP) has antineoplastic activity in vitro and in murine tumor systems, but there are no data in humans defining its potential use as an antineoplastic agent. We conducted a Phase I study to determine the spectrum of toxicity, maximum safely tolerated dose (MTD), and pharma